6DP-24085-78095
2 vaccinations
6 coded responses
24 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 972 / OR
- Registered
- 2021-03-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-14
Registered in v-safe
- 2021-03-14
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
-
2021-03-27
Survey response — day 14, dose 1MedDRA: Dyspnoea, Muscle disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shortness of breath. Not extreme, but when exercising, muscles go anaerobic far sooner than normal for a given level of effort. People have been commenting for some time about my more labored breathing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — day 21, single doseMedDRA: Dyspnoea — Feeling: FairFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — day 28, single doseMedDRA: Cough, Dyspnoea exertional, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Difficulty breathing while exercising. Fatigue. Dry cough.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — day 35, single doseMedDRA: Cough, Dyspnoea, Productive cough, Wheezing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Phlegm and blood clots from sinus. Wheezing and shortness of breath when exercising vigorously. Dry cough, though that's improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-06-12
-
2021-09-11
Survey response — 6 months, dose 1MedDRA: Fall, Injury, Loss of consciousness — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Suddenly passing out and remaining unconscious despite injury during the fall.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-11
Report sent to call center — 6 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-15
-
2021-10-25
Dose 2 — Pfizer-BioNTech
-
2021-10-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-31
-
2021-11-03
Survey response — day 7, dose 2MedDRA: Dyspnoea, Presyncope — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: More difficult to breathe than usual. Partial faintingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2022-01-24
- 2022-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 14, dose 1
Symptoms: Shortness of breath. Not extreme, but when exercising, muscles go anaerobic far sooner than normal for a given level of effort. People have been commenting for some time about my more labored breathing.
Release 6 — day 21, single dose
Symptoms: Shortness of breath
Release 7 — day 28, single dose
Symptoms: Difficulty breathing while exercising. Fatigue. Dry cough.
Release 7 — day 35, single dose
Symptoms: Phlegm and blood clots from sinus. Wheezing and shortness of breath when exercising vigorously. Dry cough, though that's improving
Release 9 — 6 months, dose 1
Symptoms: Suddenly passing out and remaining unconscious despite injury during the fall.
Release 10 — day 7, dose 2
Systemic reaction (other): More difficult to breathe than usual. Partial fainting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SD | Fall | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Injury | · | · | ✓ |
| SD | Loss of consciousness | · | · | ✓ |
| SD | Muscle disorder | ✓ | ✓ | ✓ |
| SD | Productive cough | ✓ | ✓ | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Presyncope | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release